NCT01696331

Brief Summary

Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

September 27, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 1, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
Last Updated

April 19, 2018

Status Verified

April 1, 2018

Enrollment Period

4 months

First QC Date

September 27, 2012

Last Update Submit

April 17, 2018

Conditions

Liver TransplantAdherence

Outcome Measures

Primary Outcomes (1)

  • Adherence to lab tests

    One year

Secondary Outcomes (1)

  • Texting responses

    1 year

Study Arms (1)

Text Message Reminder

EXPERIMENTAL
Behavioral: Text Message Reminder

Interventions

Text Message ReminderBEHAVIORAL

Sent TM reminder at beginning and end of each month that corresponded to required lab frequency. Patients were able to send autoresponses.

Text Message Reminder

Eligibility Criteria

Age12 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patient \>12 years
  • Received liver transplant
  • Followed by Stanford Liver Transplant Team

You may not qualify if:

  • No personal cell phone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lucile Packard Children's Hospital

Palo Alto, California, 94304, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Instructor, Department of Pediatric Gastroenterology

Study Record Dates

First Submitted

September 27, 2012

First Posted

October 1, 2012

Study Start

September 1, 2012

Primary Completion

January 1, 2013

Study Completion

January 1, 2013

Last Updated

April 19, 2018

Record last verified: 2018-04

Locations

US(1)